title: Pharmacokinetics of tacrolimus (FK506) in primary orthotopic heart transplant patients.
authors.affiliation: Fujisawa GmbH, Munich, Germany.
authors.forename: N A
authors.initials: NA
authors.lastname: Undre
authors.forename: B M
authors.initials: BM
authors.lastname: Meiser
authors.forename: P
authors.initials: P
authors.lastname: Uberfuhr
authors.forename: B
authors.initials: B
authors.lastname: Reichart
authors.forename: P
authors.initials: P
authors.lastname: Stevenson
authors.forename: A
authors.initials: A
authors.lastname: Schäfer
authors.forename: A
authors.initials: A
authors.lastname: Möller
mesh_terms: D000328:Adult; D002851:Chromatography, High Pressure Liquid; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D008297:Male; D013058:Mass Spectrometry; D008657:Metabolic Clearance Rate; D012044:Regression Analysis; D016559:Tacrolimus / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus